 Focusing on 25 micro-cap companies with key catalysts andor strong performance in the current market PRINCETON, N.J. , Jan. 19, 2023 PRNewswire -- Soligenix, Inc. Nasdaq: SNGX Soligenix or the Company, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it will be presenting at the upcoming Virtual Investor Summit on January 26, 2023. 